Supplemental MRI for Women with Dense Breasts

In a model-based analysis, adding MRI based on breast density averted a few more deaths but led to many more false-positive results.

Starting in September 2024, the U.S. Food and Drug Administration is requiring that mammogram results provided to patients include assessment of breast density. For women with dense breasts, the results must state, “other imaging tests in addition to a mammogram may help find cancers.” Appropriate follow-up of such notifications remains uncertain, with recent U.S. Preventive Services Task Force guidelines citing insufficient evidence to recommend for or against supplemental screening based on breast density (NEJM JW Gen Med Jun 1 2024 and JAMA 2024; 331:1918).

In this study, researchers used well-established models to simulate outcomes if magnetic resonance imaging (MRI) were added to digital breast tomosynthesis (DBT) based on breast densit…

Reviewing Author

Molly S. Brett, MD

Disclosures

Nothing to disclose

Molly S. Brett, MD

Disclosures

Nothing to disclose

Supplemental MRI for Women with Dense Breasts

Topics

Reviewing Author